Solventum (SOLV) Competitors $77.90 -0.35 (-0.45%) Closing price 07/3/2025 03:40 PM EasternExtended Trading$77.90 0.00 (0.00%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, IRTC, NARI, and BLCOShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry. Solventum vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Penumbra Stevanato Group Glaukos iRhythm Technologies Inari Medical Bausch + Lomb GE HealthCare Technologies (NASDAQ:GEHC) and Solventum (NYSE:SOLV) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends. Is GEHC or SOLV more profitable? GE HealthCare Technologies has a net margin of 11.02% compared to Solventum's net margin of 4.55%. Solventum's return on equity of 31.01% beat GE HealthCare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies11.02% 24.95% 6.38% Solventum 4.55%31.01%6.53% Do institutionals and insiders have more ownership in GEHC or SOLV? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 0.1% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, GEHC or SOLV? GE HealthCare Technologies has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Solventum has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Which has stronger valuation and earnings, GEHC or SOLV? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.67B1.77$1.99B$4.7516.03Solventum$8.25B1.63$478M$2.1636.06 Do analysts rate GEHC or SOLV? GE HealthCare Technologies currently has a consensus target price of $88.27, indicating a potential upside of 15.93%. Solventum has a consensus target price of $81.50, indicating a potential upside of 4.62%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83Solventum 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 Does the media refer more to GEHC or SOLV? In the previous week, GE HealthCare Technologies had 11 more articles in the media than Solventum. MarketBeat recorded 24 mentions for GE HealthCare Technologies and 13 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 1.38 beat Solventum's score of 1.19 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 18 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGE HealthCare Technologies beats Solventum on 14 of the 17 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$13.58B$7.31B$5.56B$20.73BDividend YieldN/A2.78%5.24%3.72%P/E Ratio36.0627.9427.6528.06Price / Sales1.6332.39419.5638.45Price / Cash7.9020.3926.2118.22Price / Book4.556.698.034.61Net Income$478M$233.06M$3.18B$983.39M7 Day Performance3.35%3.33%2.93%2.79%1 Month Performance4.11%1.79%1.72%4.37%1 Year Performance56.11%37.40%34.39%15.08% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum1.4521 of 5 stars$77.90-0.4%$81.50+4.6%+56.1%$13.58B$8.25B36.0622,000News CoveragePositive NewsAnalyst UpgradeGEHCGE HealthCare Technologies4.1264 of 5 stars$74.07-0.4%$88.27+19.2%-1.2%$33.92B$19.67B15.5950,000News CoveragePositive NewsDividend AnnouncementPHGKoninklijke Philips3.6779 of 5 stars$23.99-0.6%N/A-9.7%$23.10B$19.50B55.7978,200ZBHZimmer Biomet4.8835 of 5 stars$91.23-0.3%$111.53+22.2%-13.3%$18.05B$7.70B20.1817,000News CoverageSNNSmith & Nephew SNATS3.0801 of 5 stars$30.67+1.5%$28.00-8.7%+12.9%$13.43B$5.81B14.2017,349PENPenumbra4.7248 of 5 stars$256.00-0.2%$302.40+18.1%+38.3%$9.91B$1.19B241.514,500Positive NewsInsider TradeSTVNStevanato Group1.5312 of 5 stars€24.51-0.5%N/A+32.7%€7.42B€1.19B48.065,521News CoveragePositive NewsGap DownGKOSGlaukos4.5563 of 5 stars$103.42+2.0%$134.67+30.2%-14.9%$5.91B$383.48M-43.64780Positive NewsIRTCiRhythm Technologies1.1591 of 5 stars$153.96-0.5%$138.60-10.0%+43.1%$4.92B$618.59M-49.032,000Insider TradeNARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800BLCOBausch + Lomb3.0868 of 5 stars$13.03+5.1%$15.54+19.3%-6.0%$4.61B$4.79B-12.6513,500High Trading Volume Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives GKOS Alternatives IRTC Alternatives NARI Alternatives BLCO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOLV Stock Alerts